Commentary: The concept of 'Mendelian randomization'

International Journal of Epidemiology

Volumn 33, Issue 1, 2004, Pages 21-25

  Thomas, Duncan C ^a   Conti, David V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN A; ASCORBIC ACID; CHOLESTEROL; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE;

ALLELE; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CHOLESTEROL BLOOD LEVEL; ENVIRONMENTAL FACTOR; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; NEURAL TUBE DEFECT; NONLINEAR SYSTEM; OVARY CANCER; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; RANDOMIZATION; VITAMIN BLOOD LEVEL;

BIAS (EPIDEMIOLOGY); CAUSALITY; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 1942507436     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh048     Document Type: Article

References (29)

1. Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1986;i:507-08.
2. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
3. Clayton DG, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358:1357-60.
4. Keavney B. Genetic epidemiological studies of coronary heart disease. Int J Epidemiol 2002;31:730-36.
5. Youngman L, Keavney B, Palmer A et al. Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by 'Mendelian randomization'. Circulation 2000;102(Suppl.2):31-32.
6. Little J, Khoury MJ. Mendelian randomization: a new spin or real progress? Lancet 2003;362:930-31.
7. Wright S. Appendix. In: Wright PG (ed.). The Tariff on Animal and Vegetable Oils. New York: Macmillan, 1928.
8. Buzas JS, Stefanski LA. Instrumental variable estimation in generalized linear measurement error models. J Am Statist Assoc 1996; 91:999-1006.
9. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Fpidemiol 2000;29:722-29.
10. Pearl J. Causality: Models, Reasoning, and Inference. Cambridge: Cambridge University Press, 2000.
11. Berkson. Are there two regressions? J Am Statist Assoc 1950;45: 164-80.
12. Thomas DC, Stram D, Dwyer J. Exposure measurement error: Influence on exposure-disease relationships and methods of correction. Ann Rev Public Health 1993;14:69-93.
13. Fuller W. Measurement Error Models. New York: Wiley, 1987.
14. Thompson JR, Tobin MD, Minelli C. On the accuracy of estimates of the effect of phenotype on disease derived from Mendelian randomisation studies. Technical report 2003-GE1. Leicester: University of Leicester (available from http://www.prw.le.ac.uk/research/HCG/research.html). 2003.
15. Friso S, Choi SW, Girelli D et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002;99:5606-11.
16. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001;98: 14853-58.
17. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21: 35-50.
18. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361: 865-72.
19. Rothman N, Wacholder S, Caporaso NE, Garcia-Closas M, Buetow K, Fraumeni JF Jr. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochimica Biophysica Acta 2001;1471:C1-10.
20. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002; 23:381-87.
21. Thomas DC, Witte JS. Point: Population stratification: A problem for case-control studies of candidate gene associations? Cancer Epidemiol Biomarkers Prev 2002;11:505-12.
22. Wacholder S, Rothman N, Caporaso N. Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiologic studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 2002;11: 513-20.
23. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
24. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
25. Self SG, Longton G, Kopecky KJ, Liang KY. On estimating HLA/disease association with application to a study of aplastic anemia. Biometrics 1991;47:53-61.
26. Curtis D. Use of siblings as controls in case-control association studies. Ann Hum Genet 1997;61:319-33.
27. Lunetta KL, Faraone SV, Biederman J, Laird NM. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet 2000;66:605-14.
28. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000;50:211-23.
29. Shih MC, Whittemore AS. Tests for genetic association using family data. Genet Epidemiol 2002;22:128-45.